Allarity Therapeutics, Inc. SEC filings ALLR
Allarity Therapeutics, Inc. has 403 filings in SEC EDGAR's recent list, going back to May 27, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 26, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Apr 10, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 13, 2025 |
| DEFA14A | Additional proxy material | Jul 26, 2024 | — |
| DEF 14A | Proxy statement | Jul 1, 2024 | Jul 26, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 21, 2024 | Jun 21, 2024 |
| DEF 14A | Proxy statement | Mar 8, 2024 | Apr 1, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 26, 2024 | Jan 26, 2024 |
| DEFA14A | Additional proxy material | Jun 20, 2023 | — |
| DEF 14A | Proxy statement | Jun 6, 2023 | Jun 20, 2023 |
| PRE 14A | Preliminary proxy statement | May 26, 2023 | May 26, 2023 |
| DEF 14A | Proxy statement | Mar 6, 2023 | Mar 20, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 24, 2023 | Feb 24, 2023 |
| DEFA14A | Additional proxy material | Jan 24, 2023 | — |
| DEF 14A | Proxy statement | Dec 6, 2022 | Jan 19, 2023 |
| DEFA14A | Additional proxy material | Dec 6, 2022 | — |
| PRE 14A | Preliminary proxy statement | Nov 25, 2022 | Nov 25, 2022 |
| DEFA14A | Additional proxy material | Nov 8, 2022 | — |
| DEFA14A | Additional proxy material | Sep 26, 2022 | — |
| DEFA14A | Additional proxy material | Sep 19, 2022 | — |
| DEF 14A | Proxy statement | Sep 19, 2022 | Nov 4, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 8, 2022 | Sep 8, 2022 |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALLR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1860657
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.